1. Cell Mol Gastroenterol Hepatol. 2020;9(3):545-546. doi: 
10.1016/j.jcmgh.2019.11.014. Epub 2019 Dec 25.

Staging NAFLD: Diagnostic and Therapeutic Value of TAM Signaling.

Cubero FJ(1).

Author information:
(1)Department of Immunology, Ophthalmology and ENT, Complutense University 
School of Medicine, 12 de Octubre Health Research Institute (imas12), Madrid, 
Spain. Electronic address: fcubero@ucm.es.

Comment on
    Cell Mol Gastroenterol Hepatol. 2020;9(3):349-368. doi: 
10.1016/j.jcmgh.2019.10.010.

DOI: 10.1016/j.jcmgh.2019.11.014
PMCID: PMC7078440
PMID: 31881182 [Indexed for MEDLINE]